Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.

Hervé PL, Lorin V, Jouvion G, Da Costa B, Escriou N.

Virology. 2015 Dec;486:134-45. doi: 10.1016/j.virol.2015.08.033. Epub 2015 Oct 1.

2.

Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction.

Marnata C, Saulnier A, Mompelat D, Krey T, Cohen L, Boukadida C, Warter L, Fresquet J, Vasiliauskaite I, Escriou N, Cosset FL, Rey FA, Lanford RE, Karayiannis P, Rose NJ, Lavillette D, Martin A.

J Virol. 2015 Dec;89(23):12131-44. doi: 10.1128/JVI.01161-15. Epub 2015 Sep 23.

3.

Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein.

Escriou N, Callendret B, Lorin V, Combredet C, Marianneau P, Février M, Tangy F.

Virology. 2014 Mar;452-453:32-41. doi: 10.1016/j.virol.2014.01.002. Epub 2014 Jan 28.

4.

Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity.

Lucas-Hourani M, Dauzonne D, Jorda P, Cousin G, Lupan A, Helynck O, Caignard G, Janvier G, André-Leroux G, Khiar S, Escriou N, Desprès P, Jacob Y, Munier-Lehmann H, Tangy F, Vidalain PO.

PLoS Pathog. 2013;9(10):e1003678. doi: 10.1371/journal.ppat.1003678. Epub 2013 Oct 3.

5.

Kinetic characterization of PB1-F2-mediated immunopathology during highly pathogenic avian H5N1 influenza virus infection.

Leymarie O, Jouvion G, Hervé PL, Chevalier C, Lorin V, Lecardonnel J, Da Costa B, Delmas B, Escriou N, Le Goffic R.

PLoS One. 2013;8(3):e57894. doi: 10.1371/journal.pone.0057894. Epub 2013 Mar 1.

6.

A human coronavirus responsible for the common cold massively kills dendritic cells but not monocytes.

Mesel-Lemoine M, Millet J, Vidalain PO, Law H, Vabret A, Lorin V, Escriou N, Albert ML, Nal B, Tangy F.

J Virol. 2012 Jul;86(14):7577-87. doi: 10.1128/JVI.00269-12. Epub 2012 May 2.

7.

SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement.

Jaume M, Yip MS, Kam YW, Cheung CY, Kien F, Roberts A, Li PH, Dutry I, Escriou N, Daeron M, Bruzzone R, Subbarao K, Peiris JS, Nal B, Altmeyer R.

Hong Kong Med J. 2012 Feb;18 Suppl 2:31-6.

8.

Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway.

Jaume M, Yip MS, Cheung CY, Leung HL, Li PH, Kien F, Dutry I, Callendret B, Escriou N, Altmeyer R, Nal B, Daëron M, Bruzzone R, Peiris JS.

J Virol. 2011 Oct;85(20):10582-97. doi: 10.1128/JVI.00671-11. Epub 2011 Jul 20.

9.

SUMOylation promotes PML degradation during encephalomyocarditis virus infection.

El McHichi B, Regad T, Maroui MA, Rodriguez MS, Aminev A, Gerbaud S, Escriou N, Dianoux L, Chelbi-Alix MK.

J Virol. 2010 Nov;84(22):11634-45. doi: 10.1128/JVI.01321-10. Epub 2010 Sep 8.

10.

Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity.

Machado AV, Caetano BC, Barbosa RP, Salgado AP, Rabelo RH, Garcia CC, Bruna-Romero O, Escriou N, Gazzinelli RT.

Vaccine. 2010 Apr 19;28(18):3247-56. doi: 10.1016/j.vaccine.2010.02.003. Epub 2010 Feb 26.

PMID:
20189485
11.

The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles.

Siu YL, Teoh KT, Lo J, Chan CM, Kien F, Escriou N, Tsao SW, Nicholls JM, Altmeyer R, Peiris JS, Bruzzone R, Nal B.

J Virol. 2008 Nov;82(22):11318-30. doi: 10.1128/JVI.01052-08. Epub 2008 Aug 27.

12.

Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation.

Mouriès J, Moron G, Schlecht G, Escriou N, Dadaglio G, Leclerc C.

Blood. 2008 Nov 1;112(9):3713-22. doi: 10.1182/blood-2008-03-146290. Epub 2008 Aug 12.

13.

Delivery of mengovirus-derived RNA replicons into tumoural liver enhances the anti-tumour efficacy of a peripheral peptide-based vaccine.

Couty JP, Crain AM, Gerbaud S, Labasque M, Marchiol C, Fradelizi D, Boudaly S, Guettier C, Vignuzzi M, van der Werf S, Escriou N, Viguier M.

Cancer Immunol Immunother. 2008 Aug;57(8):1161-71. doi: 10.1007/s00262-007-0448-3. Epub 2008 Feb 7.

PMID:
18256833
14.

Antigen crosspresentation by human plasmacytoid dendritic cells.

Hoeffel G, Ripoche AC, Matheoud D, Nascimbeni M, Escriou N, Lebon P, Heshmati F, Guillet JG, Gannagé M, Caillat-Zucman S, Casartelli N, Schwartz O, De la Salle H, Hanau D, Hosmalin A, Marañón C.

Immunity. 2007 Sep;27(3):481-92.

15.

Codon conservation in the influenza A virus genome defines RNA packaging signals.

Gog JR, Afonso Edos S, Dalton RM, Leclercq I, Tiley L, Elton D, von Kirchbach JC, Naffakh N, Escriou N, Digard P.

Nucleic Acids Res. 2007;35(6):1897-907. Epub 2007 Mar 1.

16.

Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS.

Callendret B, Lorin V, Charneau P, Marianneau P, Contamin H, Betton JM, van der Werf S, Escriou N.

Virology. 2007 Jul 5;363(2):288-302. Epub 2007 Feb 28.

17.

Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia.

Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M.

PLoS Pathog. 2006 Jun;2(6):e53. Epub 2006 Jun 9.

18.
20.

Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosis.

Mégret F, Prehaud C, Lafage M, Batejat C, Escriou N, Lay S, Thoulouze MI, Lafon M.

Vaccine. 2005 Nov 16;23(46-47):5342-50. Epub 2005 Jul 18.

21.

Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E.

Nal B, Chan C, Kien F, Siu L, Tse J, Chu K, Kam J, Staropoli I, Crescenzo-Chaigne B, Escriou N, van der Werf S, Yuen KY, Altmeyer R.

J Gen Virol. 2005 May;86(Pt 5):1423-34.

PMID:
15831954
22.

Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus.

Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-Tahar M.

J Biol Chem. 2005 Feb 18;280(7):5571-80. Epub 2004 Dec 3.

23.

Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation.

Schlecht G, Garcia S, Escriou N, Freitas AA, Leclerc C, Dadaglio G.

Blood. 2004 Sep 15;104(6):1808-15. Epub 2004 May 27.

24.

Introduction of SARS in France, March-April, 2003.

Desenclos JC, van der Werf S, Bonmarin I, Levy-Bruhl D, Yazdanpanah Y, Hoen B, Emmanuelli J, Lesens O, Dupon M, Natali F, Michelet C, Reynes J, Guery B, Larsen C, Semaille C, Mouton D, André M, Escriou N, Burguière A, Manuguerra JC, Coignard B, Lepoutre A, Meffre C, Bitar D, Decludt B, Capek I, Antona D, Che D, Herida M, Infuso A, Sauri C, Brücker G, Hubert B, LeGoff D, Scheidegger S.

Emerg Infect Dis. 2004 Feb;10(2):195-200.

25.
26.

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, Laman JD, de Jong T, van Doornum G, Lim W, Ling AE, Chan PK, Tam JS, Zambon MC, Gopal R, Drosten C, van der Werf S, Escriou N, Manuguerra JC, Stöhr K, Peiris JS, Osterhaus AD.

Lancet. 2003 Jul 26;362(9380):263-70.

PMID:
12892955
27.

HLA-B*0702 transgenic, H-2KbDb double-knockout mice: phenotypical and functional characterization in response to influenza virus.

Rohrlich PS, Cardinaud S, Firat H, Lamari M, Briand P, Escriou N, Lemonnier FA.

Int Immunol. 2003 Jun;15(6):765-72.

PMID:
12750360
28.

Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Drosten C, Günther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguière AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Müller S, Rickerts V, Stürmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW.

N Engl J Med. 2003 May 15;348(20):1967-76. Epub 2003 Apr 10.

29.
30.

Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes.

Medeiros R, Escriou N, Naffakh N, Manuguerra JC, van der Werf S.

Virology. 2001 Oct 10;289(1):74-85.

32.

Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A viruses.

Naffakh N, Massin P, Escriou N, Crescenzo-Chaigne B, van der Werf S.

J Gen Virol. 2000 May;81(Pt 5):1283-91.

PMID:
10769071
33.

A coding RNA sequence acts as a replication signal in cardioviruses.

Lobert PE, Escriou N, Ruelle J, Michiels T.

Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11560-5.

34.

Chronic intravenous injections of antigen induce and maintain tolerance in T cell receptor-transgenic mice.

Bercovici N, Delon J, Cambouris C, Escriou N, Debré P, Liblau RS.

Eur J Immunol. 1999 Jan;29(1):345-54.

35.
36.

Processing of the E1 glycoprotein of hepatitis C virus expressed in mammalian cells.

Fournillier Jacob A, Cahour A, Escriou N, Girard M, Wychowski C.

J Gen Virol. 1996 May;77 ( Pt 5):1055-64.

PMID:
8609471
38.

Cytotoxic T cell response to Mengo virus in mice: effector cell phenotype and target proteins.

Escriou N, Leclerc C, Gerbard S, Giraud M, van der Werf S.

J Gen Virol. 1995 Aug;76 ( Pt 8):1999-2007.

PMID:
7636480
39.

Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120.

Altmeyer R, Escriou N, Girard M, Palmenberg A, van der Werf S.

Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9775-9.

40.

Supplemental Content

Loading ...
Support Center